151 related articles for article (PubMed ID: 18549351)
1. Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line.
Lankat-Buttgereit B; Müller S; Schmidt H; Parhofer KG; Gress TM; Göke R
Biol Cell; 2008 Dec; 100(12):703-15. PubMed ID: 18549351
[TBL] [Abstract][Full Text] [Related]
2. Knock-down of Pdcd4 stimulates angiogenesis via up-regulation of angiopoietin-2.
Krug S; Huth J; Göke F; Buchholz M; Gress TM; Göke R; Lankat-Buttgereit B
Biochim Biophys Acta; 2012 Apr; 1823(4):789-99. PubMed ID: 22289349
[TBL] [Abstract][Full Text] [Related]
3. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms.
Nakashima M; Hamajima H; Xia J; Iwane S; Kwaguchi Y; Eguchi Y; Mizuta T; Fujimoto K; Ozaki I; Matsuhashi S
Biochim Biophys Acta; 2010 Sep; 1803(9):1020-7. PubMed ID: 20471435
[TBL] [Abstract][Full Text] [Related]
5. Proprotein convertase 1 mediated proneuropeptide proteolytic processing in ischemic neuron injury.
Tang SS; Liang ZY; Guo LR; Zhang JH; Zhou D
Bratisl Lek Listy; 2017; 118(10):609-612. PubMed ID: 29198128
[TBL] [Abstract][Full Text] [Related]
6. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.
Dikshit B; Irshad K; Madan E; Aggarwal N; Sarkar C; Chandra PS; Gupta DK; Chattopadhyay P; Sinha S; Chosdol K
Oncogene; 2013 Aug; 32(33):3798-808. PubMed ID: 22986533
[TBL] [Abstract][Full Text] [Related]
7. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.
Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I
Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270
[TBL] [Abstract][Full Text] [Related]
8. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
Portela-Gomes GM; Grimelius L; Stridsberg M
Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
Yang HS; Matthews CP; Clair T; Wang Q; Baker AR; Li CC; Tan TH; Colburn NH
Mol Cell Biol; 2006 Feb; 26(4):1297-306. PubMed ID: 16449643
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway.
Wang WQ; Zhang H; Wang HB; Sun YG; Peng ZH; Zhou G; Yang SM; Wang RQ; Fang DC
Mol Diagn Ther; 2010 Jun; 14(3):155-61. PubMed ID: 20560677
[TBL] [Abstract][Full Text] [Related]
11. siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression.
Bitomsky N; Wethkamp N; Marikkannu R; Klempnauer KH
Oncogene; 2008 Aug; 27(35):4820-9. PubMed ID: 18427550
[TBL] [Abstract][Full Text] [Related]
12. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation.
Lankat-Buttgereit B; Göke R
Biol Cell; 2009 Jun; 101(6):309-17. PubMed ID: 19356152
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells.
Gong J; Lee J; Akio H; Schlegel PN; Shen R
Endocrinology; 2007 Sep; 148(9):4489-99. PubMed ID: 17584963
[TBL] [Abstract][Full Text] [Related]
14. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells.
Lankat-Buttgereit B; Lenschen B; Schmidt H; Göke R
Apoptosis; 2008 Jan; 13(1):157-64. PubMed ID: 17955371
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion.
González-Villasana V; Nieves-Alicea R; McMurtry V; Gutiérrez-Puente Y; Tari AM
Oncol Rep; 2012 Mar; 27(3):861-6. PubMed ID: 22200873
[TBL] [Abstract][Full Text] [Related]
16. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
Cuesta R; Holz MK
Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
[TBL] [Abstract][Full Text] [Related]
17. mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells.
Vikhreva PN; Shepelev MV; Korobko IV
Biochim Biophys Acta; 2014 Jan; 1839(1):43-9. PubMed ID: 24334141
[TBL] [Abstract][Full Text] [Related]
18. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.
Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
Cancer Res; 2005 Dec; 65(24):11282-6. PubMed ID: 16357133
[TBL] [Abstract][Full Text] [Related]
19. Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer.
Wei N; Liu SS; Chan KK; Ngan HY
PLoS One; 2012; 7(1):e30311. PubMed ID: 22272332
[TBL] [Abstract][Full Text] [Related]
20. Expression of Pdcd4 tumor suppressor in human melanoma cells.
Vikhreva PN; Korobko IV
Anticancer Res; 2014 May; 34(5):2315-8. PubMed ID: 24778037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
